Literature DB >> 3113288

Cerebral autoregulation and flow/metabolism coupling during cardiopulmonary bypass: the influence of PaCO2.

J M Murkin, J K Farrar, W A Tweed, F N McKenzie, G Guiraudon.   

Abstract

Measurement of 133Xe clearance and effluent cerebral venous blood sampling were used in 38 patients to determine the effects of cardiopulmonary bypass, and of maintaining temperature corrected or noncorrected PaCO2 at 40 mm Hg on regulation of cerebral blood flow (CBF) and flow/metabolism coupling. After induction of anesthesia with diazepam and fentanyl, mean CBF was 25 ml X 100 g-1 X min-1 and cerebral oxygen consumption, 1.67 ml X 100 g-1 X min-1. Cerebral oxygen consumption during nonpulsatile cardiopulmonary bypass at 26 degrees C was reduced to 0.42 ml X 100 g-1 X min-1 in both groups. CBF was reduced to 14-15 ml X 100 g-1 X min-1 in the non-temperature-corrected group (n = 21), was independent of cerebral perfusion pressure over the range of 20-100 mm Hg, but correlated with cerebral oxygen consumption. In the temperature-corrected group (n = 17), CBF varied from 22 to 32 ml X 100 g-1 X min-1, and flow/metabolism coupling was not maintained (i.e., CBF and cerebral oxygen consumption varied independently). However, variation in CBF correlated significantly with cerebral perfusion pressure over the pressure range of 15-95 mm Hg. This study demonstrates a profound reduction in cerebral oxygen consumption during hypothermic nonpulsatile cardiopulmonary bypass. When a non-temperature-corrected PaCO2 of approximately 40 mm Hg was maintained, CBF was lower, and analysis of pooled data suggested that CBF regulation was better preserved, i.e., CBF was independent of pressure changes and dependent upon cerebral oxygen consumption.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3113288

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  40 in total

1.  Risks for impaired cerebral autoregulation during cardiopulmonary bypass and postoperative stroke.

Authors:  M Ono; B Joshi; K Brady; R B Easley; Y Zheng; C Brown; W Baumgartner; C W Hogue
Journal:  Br J Anaesth       Date:  2012-06-01       Impact factor: 9.166

Review 2.  Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials?

Authors:  H Bart van der Worp; Malcolm R Macleod; Rainer Kollmar
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-31       Impact factor: 6.200

3.  [Near-infrared spectroscopy during hypothermic selective cerebral perfusion--a clinical study of its value].

Authors:  T Ito; T Ueda; T Omoto; K Moro; A Mitsumaru; T Goto; R Yozu; S Kawada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-12

Review 4.  Pathophysiology of cardiopulmonary bypass.

Authors:  J M Murkin
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

Review 5.  [Why does blood have a pH-value of 7.4? The theory of acid-base management].

Authors:  M H Dueck; M Paul; R H Wiesner; U Boerner
Journal:  Anaesthesist       Date:  2004-11       Impact factor: 1.041

Review 6.  What blood pressure is appropriate for cardiopulmonary bypass and how to get it.

Authors:  Alan Merry
Journal:  J Extra Corpor Technol       Date:  2006-03

Review 7.  [Therapeutic hypothermia and acid-base management].

Authors:  F Bach; F Mertzlufft
Journal:  Anaesthesist       Date:  2007-04       Impact factor: 1.041

8.  Evaluating the accuracy of perfusion/metabolism (SPET/PET) ratio in seizure localization.

Authors:  K Buch; H Blumenfeld; S Spencer; E Novotny; I G Zubal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-16       Impact factor: 9.236

9.  Noninvasive measurement of cerebral blood flow: techniques and limitations.

Authors:  J M Murkin; D H Lee
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063

10.  Impaired autoregulation of cerebral blood flow during rewarming from hypothermic cardiopulmonary bypass and its potential association with stroke.

Authors:  Brijen Joshi; Kenneth Brady; Jennifer Lee; Blaine Easley; Rabi Panigrahi; Peter Smielewski; Marek Czosnyka; Charles W Hogue
Journal:  Anesth Analg       Date:  2009-12-11       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.